Role of myeloid-specific G-protein coupled receptor kinase-2 in sepsis

International Journal of Clinical and Experimental Medicine

Volumn 4, Issue 4, 2011, Pages 320-330

  Parvataneni, Sitaram ^a   Gonipeta, Babu ^a   Packiriswamy, Nandakumar ^a   Lee, Taehyung ^a   Durairaj, Haritha ^a   Parameswaran, Narayanan ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

G protein coupled receptor kinase 2 (GRK2); GRK2 knockout mice; Inflammation; Sepsis

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 2; INTERLEUKIN 10; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BONE MARROW CELL; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME ACTIVITY; IMMUNOCOMPETENT CELL; INFLAMMATION; KNOCKOUT MOUSE; LIGATION; LUNG LAVAGE; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEAL FLUID; PROTEIN BLOOD LEVEL; PUNCTURE; SEPSIS; SURVIVAL; WILD TYPE;

EID: 82955168434     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Penn RB, Pronin AN, Benovic JL Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 2000; 10: 81-89.
2. Kleibeuker W, Jurado Pueyo M, Murga C, Eijkelkamp N, Mayor F Jr, Heijnen CJ, Kavelaars A. Physiological changes in GRK2 regulate CCL2- induced signaling to ERK1/2 and Akt but not to MEK1/2 and calcium. J Neurochem 2008; 104: 979-992.
3. Parameswaran N, Pao CS, Leonhard KS, Kang DS, Kratz M, Ley SC, Benovic JL. Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J Biol Chem 2006; 281: 34159-34170.
4. Patial S, Luo J, Porter KJ, Benovic JL, Parameswaran N. G-protein coupled receptor kinases mediate TNFa-induced NFκB signaling via direct interaction with and phosphorylation of IκBα. Biochem J 2009; 425: 169-178.
5. Peregrin S, Jurado Pueyo M, Campos PM, Sanz Moreno V, Ruiz Gomez A, Mayor F Jr, Murga C. Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Curr Biol 2006; 16: 2042-2047.
6. Ribas C, Penela P, Murga C, Salcedo A, Garcia Hoz C, Jurado Pueyo M, Aymerich I, Mayor F Jr. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 2007; 1768: 913-922.
7. Vroon A, Heijnen CJ, Lombardi MS, Cobelens PM, Mayor F Jr, Caron MG, Kavelaars A. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukoc Biol 2004; 75: 901-909.
8. Parameswaran N, Patial S. Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010; 20: 87-103.
9. Patial S, Saini Y, Parvataneni S, Appledorn DM, Dorn GW 2nd, Lapres JJ, Amalfitano A, Senagore P, Parameswaran N. Myeloid-specific GPCR kinase-2 negatively regulates NF- κB1p105-ERK pathway and limits endotoxemic shock in mice. J Cell Physiol 2011; 226: 627-637.
10. Patial S, Shahi S, Saini Y, Lee T, Packiriswamy N, Appledorn DM, Lapres JJ, Amalfitano A, Parameswaran N. G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFαB activation in primary macrophages and modulates inflammation in vivo in mice. J Cell Physiol 2011; 226: 1323-1333.
11. Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci USA 1986; 83: 2797-2801.
12. Vroon A, Heijnen CJ, Kavelaars A. GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 2006; 80: 1214-1221.
13. Arraes SM, Freitas MS, da Silva SV, de Paula Neto HA, Alves Filho JC, Auxiliadora Martins M, Basile Filho A, Tavares Murta BM, Barja Fidalgo C, Cunha FQ. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006; 108: 2906-2913.
14. Leosco D, Fortunato F, Rengo G, Iaccarino G, Sanzari E, Golino L, Zincarelli C, Canonico V, Marchese M, Koch WJ, Rengo F. Lymphocyte Gprotein- coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. Neurosci Lett 2007; 415: 279-282.
15. Lombardi MS, Kavelaars A, Schedlowski M, Bijlsma JW, Okihara KL, Van de Pol M, Ochsmann S, Pawlak C, Schmidt RE, Heijnen CJ. Decreased expression and activity of Gprotein- coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. Faseb J 1999; 13: 715-725.
16. Vroon A, Kavelaars A, Limmroth V, Lombardi MS, Goebel MU, Van Dam AM, Caron MG, Schedlowski M, Heijnen CJ. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 2005; 174: 4400-4406.
17. Lombardi MS, Kavelaars A, Cobelens PM, Schmidt RE, Schedlowski M, Heijnen CJ. Adjuvant arthritis induces down-regulation of G protein- coupled receptor kinases in the immune system. J Immunol 2001; 166: 1635-1640.
18. Vroon A, Lombardi MS, Kavelaars A, Heijnen CJ. Changes in the G-protein-coupled receptor desensitization machinery during relapsingprogressive experimental allergic encephalomyelitis. J Neuroimmunol 2003; 137: 79-86.
19. Loniewski K, Shi Y, Pestka J, Parameswaran N. Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. Mol Immunol 2008; 45: 2312-2322.
20. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, Cunha FQ. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA 2009; 106: 4018-4023.
21. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007; 81: 137-143.
22. Remick DG, Ward PA. Evaluation of endotoxin models for the study of sepsis. Shock 2005; 24 Suppl 1: 7-11.
23. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277.
24. Matkovich SJ, Diwan A, Klanke JL, Hammer DJ, Marreez Y, Odley AM, Brunskill EW, Koch WJ, Schwartz RJ, Dorn GW 2nd. Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and betaadrenergic signaling. Circ Res 2006; 99: 996-1003.
25. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH. Cecal ligation and puncture. Shock 2005; 24 Suppl 1: 52-57.
26. McMaken S, Exline MC, Mehta P, Piper M, Wang Y, Fischer SN, Newland CA, Schrader CA, Balser SR, Sarkar A, Baran CP, Marsh CB, Cook CH, Phillips GS, Ali NA. Thrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity. PLoS One 2011; 6: e19654.
27. Porter KJ, Gonipeta B, Parvataneni S, Appledorn DM, Patial S, Sharma D, Gangur V, Amalfitano A, Parameswaran N. Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by ß-arrestins. J Cell Physiol 2010; 225: 406-416.
28. Coimbra R, Melbostad H, Loomis W, Tobar M, Hoyt DB. Phosphodiesterase inhibition decreases nuclear factor-κB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. J Trauma 2005; 59: 575-582.
29. Loisa P, Rinne T, Laine S, Hurme M, Kaukinen S. Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand 2003; 47: 319-325.
30. Osuchowski MF, Connett J, Welch K, Granger J, Remick DG. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 2009; 37: 1567-1573.
31. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8: 776-787.
32. Stearns Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 2011; 6: 19-48.
33. Peppel K, Zhang L, Huynh TT, Huang X, Jacobson A, Brian L, Exum ST, Hagen PO, Freedman NJ. Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells reduces neointimal hyperplasia. J Mol Cell Cardiol 2002; 34: 1399-1409.
34. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL, Keller JR. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 1991; 147: 22-28.
35. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG. Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 2003; 19: 310-313.
36. Nijboer CH, Heijnen CJ, Willemen HL, Groenendaal F, Dorn GW 2nd, van Bel F, Kavelaars A. Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice. Brain Behav Immun 2010; 24: 420-426.
37. Aragay AM, Mellado M, Frade JM, Martin AM, Jimenez Sainz MC, Martinez AC, Mayor F Jr. Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad Sci USA 1998; 95: 2985-2990.
38. Oppermann M, Mack M, Proudfoot AE, Olbrich H. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 1999; 274: 8875-8885.
39. Busillo JM, Armando S, Sengupta R, Meucci O, Bouvier M, Benovic JL. Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem 2010; 285: 7805-7817.
40. Penela P, Ribas C, Aymerich I, Mayor F Jr. New roles of G protein-coupled receptor kinase 2 (GRK2) in cell migration. Cell Adh Migr 2009; 3: 19-23.
41. Alves Filho JC, Sonego F, Souto FO, Freitas A, Verri WA Jr, Auxiliadora Martins M, Basile Filho A, McKenzie AN, Xu D, Cunha FQ, Liew FY. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010; 16: 708-712.
42. Tarrant TK, Rampersad RR, Esserman D, Rothlein LR, Liu P, Premont RT, Lefkowitz RJ, Lee DM, Patel DD. Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). Clin Immunol 2008; 129: 115-122.
43. Craciun FL, Schuller ER, Remick DG. Early enhanced local neutrophil recruitment in peritonitis- induced sepsis improves bacterial clearance and survival. J Immunol 2010; 185: 6930-6938.
44. Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV, Lambris JD, Ward PA. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003; 170: 503-507.
45. Riedemann NC, Guo RF, Hollmann TJ, Gao H, Neff TA, Reuben JS, Speyer CL, Sarma JV, Wetsel RA, Zetoune FS, Ward PA. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 2004; 18: 370-372.
46. Guo Q, Subramanian H, Gupta K, Ali H. Regulation of c3a receptor signaling in human mast cells by g protein coupled receptor kinases. PLoS One 2011; 6: e22559.
47. Suvorova ES, Gripentrog JM, Oppermann M, Miettinen HM. Role of the carboxyl terminal dileucine in phosphorylation and internalization of C5a receptor. Biochim Biophys Acta 2008; 1783: 1261-1270.
48. Langkabel P, Zwirner J, Oppermann M. Ligandinduced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by G protein- coupled receptor kinases. Eur J Immunol 1999; 29: 3035-3046.